Page last updated: 2024-11-08

emd 53998

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

EMD 53998: EMD 53998 is racemic; EMD 57439 is the (-)-isomer; EMD 57033 is the (+)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID187079
CHEMBL ID314612
SCHEMBL ID4322811
MeSH IDM0192176

Synonyms (50)

Synonym
CHEMBL314612 ,
emd-57439
emd-53998
emd-57033
emd 53,998
emd 53998
quinoline, 6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-
5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydrochinolin-6-yl)-6-methyl-3,6-dihydro-2h-1,3,4-thiadiazin-2-on
SCHEMBL4322811
5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2h-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one
3u8dr83sgs ,
(-)-emd 57439
unii-3u8dr83sgs
emd 57033
emd-53998, (-)-
q66r347ata ,
unii-q66r347ata
emd-53998, (+)-
emd 57439
quinoline, 6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-, (+)-
quinoline, 6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroxy-, (-)-
(+)emd 57033
120223-04-3
unii-3l67d8jk8x
3l67d8jk8x ,
3,6-dihydro-5-[1,2,3,4-tetrahydro-1-(3,4-dimethoxybenzoyl)-6-quinolyl]-6-methyl-2h-1,3,4-thiadiazin-2-one
IZLRMTJLQCLMKF-UHFFFAOYSA-N ,
emd-57439, (+/-)-
5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolinyl)-3,6-dihydro-6-methyl-2h-1,3,4-thiadiazin-2-one
emd-57033, (+/-)-
2h-1,3,4-thiadiazin-2-one, 5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolinyl)-3,6-dihydro-6-methyl-
emd53988
AKOS030555673
(3,4-dimethoxyphenyl)[6-(2-hydroxy-6-methyl-6h-1,3,4-thiadiazin-5-yl)-3,4-dihydroquinolin-1(2h)-yl]methanone
DTXSID90923274
(+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-methyl-3,6-dihydro-2h-1,3,4-thiadiazin-2-one
mfcd00884699
bdbm50212472
quinoline, 6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-, (-)-
emd-57439, (+)-
emd-57033, (+)-
emd-57439, (-)-
emd-57033, (-)-
(-)-6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinoline
(+)-6-(3,6-dihydro-6-methyl-2-oxo-2h-1,3,4-thiadiazin-5-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinoline
Q27257498
5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-methyl-3,6-dihydro-2h-1,3,4-thiadiazin-2-one
CS-0067615
(+)-emd 57033
HY-106844A

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The oral bioavailability of EMD 57033, a calcium sensitizing agent with poor solubility, was compared in dogs using four solid dosage form formulation approaches: a physical blend of the drug with excipients, micronization of the drug, preparation of coground mixtures and spray-drying of the drug from a nanocrystalline suspension."( Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs.
Dressman, JB; Kunath, K; Reppas, C; Vertzoni, M; Vogt, M, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
"The oral bioavailability of EMD 57033, a calcium sensitizing agent with poor solubility, was compared in dogs using four solid dosage form formulation approaches: a physical blend of the drug with excipients, micronization of the drug, preparation of coground mixtures and spray-drying of the drug from a nanocrystalline suspension."( Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs.
Dressman, JB; Kunath, K; Reppas, C; Vertzoni, M; Vogt, M, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID159685Increase in isometric force of porcine myocardial skinned fibers at 30 uM1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): representative of a novel class of purely calcium-sensitizing agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (110)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's63 (57.27)18.2507
2000's36 (32.73)29.6817
2010's9 (8.18)24.3611
2020's2 (1.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.56 (24.57)
Research Supply Index4.73 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (5.36%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other106 (94.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]